Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Maria Buti, Edward Gane, Wai Kay Seto, Henry L.Y. Chan, Wan Long Chuang, Tatjana Stepanova, Aric Josun Hui, Young Suk Lim, Rajiv Mehta, Harry L.A. Janssen, Subrat K. Acharya, John F. Flaherty, Benedetta Massetto, Andrea L. Cathcart, Kyungpil Kim, Anuj Gaggar, G. Mani Subramanian, John G. McHutchison, Calvin Q. Pan, Maurizia BrunettoNamiki Izumi, Patrick Marcellin

Research output: Contribution to journal › Article › peer-review

201 Scopus citations

Fingerprint

Dive into the research topics of 'Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial'. Together they form a unique fingerprint.

Medicine & Life Sciences